# Azienda Ospedaliera Ospedale San Carlo Borromeo

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/azienda-ospedaliera-ospedale-san-carlo-borromeo/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 22 |
| Citations | 18,936 |
| City | Milan |
| Country | IT |
| Description | Azienda Ospedaliera Ospedale San Carlo Borromeo is a research organisation in Milan, IT. OpenAlex records 340 works and 18,936 citations for it. 58 researchers list it as their most recent affiliation. |
| Homepage | http://www.sancarlo.mi.it/ |
| OpenAlex ID | https://openalex.org/I4210088346 |
| Researchers | 58 |
| ROR ID | https://ror.org/005s69p38 |
| Type | healthcare |
| Works | 340 |

## University papers

- [Gemcitabine Plus Vinorelbine Versus Vinorelbine Alone in Elderly Patients With Advanced Non–Small-Cell Lung Cancer](https://scholariq.org/papers/gemcitabine-plus-vinorelbine-versus-vinorelbine-alone-in-elderly-patients-with/)
- [The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group](https://scholariq.org/papers/the-tale-of-tils-in-breast-cancer-a-report-from-the-international-immuno/)
- [Randomized Trial Comparing Cisplatin, Gemcitabine, and Vinorelbine With Either Cisplatin and Gemcitabine or Cisplatin and Vinorelbine in Advanced Non–Small-Cell Lung Cancer: Interim Analysis of a Phase III Trial of the Southern Italy Cooperative Oncology Group](https://scholariq.org/papers/randomized-trial-comparing-cisplatin-gemcitabine-and-vinorelbine-with-either/)
- [Lapatinib in breast cancer](https://scholariq.org/papers/lapatinib-in-breast-cancer/)
- [Cisplatin, Gemcitabine, and Vinorelbine Combination Therapy in Advanced Non–Small-Cell Lung Cancer: A Phase II Randomized Study of the Southern Italy Cooperative Oncology Group](https://scholariq.org/papers/cisplatin-gemcitabine-and-vinorelbine-combination-therapy-in-advanced-non-small/)
- [Cisplatin-Based First-Line Treatment of Elderly Patients With Advanced Non–Small-Cell Lung Cancer: Joint Analysis of MILES-3 and MILES-4 Phase III Trials](https://scholariq.org/papers/cisplatin-based-first-line-treatment-of-elderly-patients-with-advanced-non-small/)
- [Exploring the associations between spiritual well-being, burden, and quality of life in family caregivers of cancer patients](https://scholariq.org/papers/exploring-the-associations-between-spiritual-well-being-burden-and-quality-of/)
- [Phase III trial comparing 3–6 months of adjuvant FOLFOX4/XELOX in stage II–III colon cancer: safety and compliance in the TOSCA trial](https://scholariq.org/papers/phase-iii-trial-comparing-3-6-months-of-adjuvant-folfox4-xelox-in-stage-ii-iii/)
- [Cisplatin, Gemcitabine, and Paclitaxel in Locally Advanced or Metastatic Non–Small-Cell Lung Cancer: A Phase I-II Study](https://scholariq.org/papers/cisplatin-gemcitabine-and-paclitaxel-in-locally-advanced-or-metastatic-non-small/)
- [HER2-Low Status Does Not Affect Survival Outcomes of Patients with Metastatic Breast Cancer (MBC) Undergoing First-Line Treatment with Endocrine Therapy plus Palbociclib: Results of a Multicenter, Retrospective Cohort Study](https://scholariq.org/papers/her2-low-status-does-not-affect-survival-outcomes-of-patients-with-metastatic/)
- [Does Family Caregiver Burden Differ Between Elderly and Younger Caregivers in Supporting Dying Patients With Cancer? An Italian Study](https://scholariq.org/papers/does-family-caregiver-burden-differ-between-elderly-and-younger-caregivers-in/)

## University researchers

- [Domenico Bilancia](https://scholariq.org/researchers/domenico-bilancia/)

## University top topics

Showing 8 of 25.

- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Veterinary Orthopedics and Neurology](https://scholariq.org/topics/veterinary-orthopedics-and-neurology/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Bone fractures and treatments](https://scholariq.org/topics/bone-fractures-and-treatments/)
- [Occupational and environmental lung diseases](https://scholariq.org/topics/occupational-and-environmental-lung-diseases/)
- [Sarcoidosis and Beryllium Toxicity Research](https://scholariq.org/topics/sarcoidosis-and-beryllium-toxicity-research/)
- [Eosinophilic Disorders and Syndromes](https://scholariq.org/topics/eosinophilic-disorders-and-syndromes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.